Ask AI
Cilta cel for Standard Risk RRMM
Extended Efficacy and Safety Outcomes With Ciltacabtagene Autoleucel (Cilta-cel) in Patients With R/R MM With Standard-Risk Cytogenetics

Released: December 09, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 09, 2025